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Abstract: Background: Engagement in cognitively stimulating activities (CA) and leisure time physical activity (PA) 
have been associated with maintaining cognitive performance and reducing the likelihood of cognitive decline in older 
adults. However, neural mechanisms underlying protective effects of these lifestyle behaviors are largely unknown. In the 
current study, we investigated the effect of self-reported PA and CA on hippocampal volume and semantic processing ac-
tivation during a fame discrimination task, as measured by functional magnetic resonance imaging (fMRI). We also exam-
ined whether possession of the apolipoprotein E (APOE) ?4 allele could moderate the effect of PA or CA on hippocampal 
structure or function. Methods: Seventy-eight healthy, cognitively intact older adults underwent baseline neuropsy-
chological assessment, hippocampal volume measurement via manually-traced structural MRI, and task-activated fMRI. 
Results: After 18 months, 27 participants declined by one standard deviation or more on follow-up neuropsychological 
testing. Logistic regression analyses revealed that CA alone or in combination with baseline hippocampal structure or 
functional activity did not predict the probability of cognitive decline. In contrast, PA interacted with APOE ?4 status such 
that engagement in PA reduced the risk of cognitive decline in APOE ?4 carriers only. Furthermore, the benefits of PA 
appeared to diminish with reduced functional activity or volume in the hippocampus. Conclusions: Our findings suggest 
that increased leisure time PA is associated with reduced probability of cognitive decline in persons who are at high risk 
for AD. The beneficial effects of PA in this group may be related to enhancement of the functional and structural integrity 
of the hippocampus. 
Keywords: Apolipoprotein E, cognitive activity, cognitive decline, functional magnetic resonance imaging, hippocampus, 
physical activity. 
INTRODUCTION 
 The current lack of effective treatments for Alzheimer’s 
disease (AD) has stimulated considerable interest in develop-
ing strategies for prevention of cognitive decline [1, 2]. A 
multidisciplinary expert panel recently reviewed the existing 
evidence for such interventions or modifiable risk factors 
that may delay AD onset or mitigate cognitive decline [3]. 
The panel concluded that there is currently insufficient evi-
dence supporting the use of pharmaceutical or nutritional 
supplements for preventing AD or cognitive decline. How-
ever, the panel also noted positive preliminary data support-
ing cognitive engagement and physical activity as possible 
interventions for maintaining or enhancing cognitive func-
tion. A recent report [4] reviewed available evidence and 
estimated that approximately half of all AD cases are attrib-
utable to modifiable risk factors, including cognitive and 
physical inactivity. Indeed, if effective in preventing cogni- 
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tive decline, such lifestyle behaviors have considerable 
promise because they are cost-effective and have few ad-
verse side effects.  
 Participation in cognitively stimulating activities (CA; 
e.g., reading, creative writing) has been proposed as a way to 
enhance cognitive reserve [5] by promoting resistance to 
cognitive decline despite the presence of brain damage or 
disease pathology [6]. Longitudinal epidemiological studies 
have demonstrated that participation in CA is associated with 
a reduced incidence of cognitive decline in late life [7-9], 
mild cognitive impairment (MCI) [10], and AD [5, 11-15]. 
CA has also been associated with superior cognitive func-
tioning in healthy older adults [16, 17]. Despite numerous 
epidemiological studies showing benefits of CA for main-
taining cognitive function, a biological mechanism for these 
effects remains elusive. Increased blood flow and metabo-
lism to the brain during CA or the effects of repetitive behav-
ioral rehearsal are possible explanations. However, effects of 
CA on brain structure or function have not been systemati-
cally examined. While the broader construct of cognitive 
reserve involves enhanced neural network efficiency associ-
ated with increasing task difficulty [6], no imaging studies 
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have looked specifically at the impact of CA on neural func-
tioning. 
 Engagement in leisure-time physical activity (PA) is an-
other common lifestyle modification for managing and pre-
venting a variety of chronic health conditions (e.g., hyperten-
sion, obesity, diabetes) [18-20]. However, it may also play a 
role in reducing likelihood of cognitive decline [21]. Longi-
tudinal epidemiological studies suggest that late-life partici-
pation in PA (e.g., walking, calisthenics) is associated with a 
reduced incidence of cognitive decline [22-29], MCI [30], 
and AD [14, 22, 31-34], and intervention studies have dem-
onstrated that engagement in PA can improve cognitive and 
attentional task performance [35-37]. One recent report [38] 
suggested that engagement in PA may also be associated 
with prolonged survival in AD patients. Animal models have 
suggested possible biological mechanisms underlying the 
positive effects of PA on cognitive function. For example, 
PA may enhance neural functioning by increasing levels of 
brain-derived neurotrophic factor (BDNF), which in turn 
mediates synaptogenesis, neurogenesis, and plasticity [39, 
40]. Exercise interventions can stimulate hippocampal neu-
rogenesis in rodents [41-48]. These enhancements may lead 
to more efficient brain functioning and confer resistance to 
future cognitive decline. Importantly, several studies have 
suggested that the beneficial effects of PA may be moderated 
by the presence of one or both apolipoprotein E (APOE) ?4 
alleles, a well-established risk factor for AD. In several stud-
ies, PA appears to exert a greater protective effect for ?4 
carriers than for non-carriers [23, 31, 49]. In contrast, an-
other study found PA preferentially benefits APOE ?4 non-
carriers [32]. Thus, the nature of the association between PA 
and cognitive decline, and how the APOE ?4 allele influ-
ences this relationship, are unclear. 
 Functional neuroimaging studies evaluating lifestyle 
modifications, such as PA and CA, may elucidate biological 
mechanisms by which these interventions confer resistance 
to late-life cognitive decline. Several of the previously dis-
cussed animal studies suggest that biological changes in the 
hippocampus may underlie some of the benefits of interven-
tions such as PA. The purpose of the current study was to 
evaluate whether PA and CA may reduce the risk of cogni-
tive decline independent of hippocampal volume and func-
tion. We used a famous name discrimination task during 
functional magnetic resonance imaging (fMRI) that has con-
sistently revealed greater semantic processing activity in 
persons at-risk for AD (cognitively intact older APOE ?4 
carriers [50] and persons with MCI [51]) relative to persons 
not at-risk. A longitudinal follow-up study using this task 
demonstrated that healthy older adults with greater baseline 
semantic processing activity in cortical and hippocampal 
regions and larger baseline hippocampal volumes (particu-
larly in APOE ?4 carriers) showed greater stability in cogni-
tive functioning over 18 months [52]. In a subsequent cross-
sectional study, persons who reported engaging in regular 
PA exhibited greater cortical semantic processing activity on 
this task, particularly among APOE ?4 positive participants 
[53]. Thus, the current study was designed to extend the re-
sults of these previous studies by comparing the effects of 
PA, CA, and hippocampal activity and volume on cognitive 
decline. Because we observed the protective effect of in-
creased semantic processing activation to be strongest in 
APOE ?4 allele carriers [52] and because PA was associated 
with the greatest increase in semantic processing activation 
for APOE ?4 allele carriers [53], we predicted that the pres-
ence of the APOE ?4 allele and increased hippocampal 
activation would potentiate the protective influences of PA 
or CA on resistance to cognitive decline. 
MATERIAL AND METHODS 
Participants 
 Participants were recruited via newspaper advertise-
ments. In order to enrich our sample with participants who 
were at-risk for AD, half of the participants were selected on 
the basis of having a family history of dementia, defined as 
having a first-degree relative with a formal diagnosis of AD 
prior to death or a reported history of dementia-like symp-
toms without a diagnosis. Because of the elevated proportion 
of individuals with a family history of dementia, the repre-
sentation of APOE ?4 carriers was also greater in our sample 
than in the general population.  
 Participants were required to be cognitively intact and 
non-demented upon study entry. They were excluded if they 
scored less than 25 on the Mini-Mental State Exam (MMSE) 
[54] or more than 1.5 standard deviations below age-
appropriate means on the Rey Auditory Verbal Learning 
Test (RAVLT) [55]; Mattis Dementia Rating Scale-2 
(MDRS-2) [56-58]. Participants were also excluded if they 
obtained a score greater than 10 on the Geriatric Depression 
Scale (GDS) [59, 60] “or” if they demonstrated any impair-
ment of activities of daily living on the Lawton and Brody 
Self-Maintaining and Instrumental Activities of Daily Living 
Scale [61]. Finally, participants were excluded if they had a 
history or evidence of: 1) significant neurological ill-
nesses/conditions; 2) medical illnesses/conditions that may 
affect brain function; 3) current psychiatric disturbance or 
substance abuse or dependence meeting DSM-IV Axis I 
criteria; 4) contraindications specific to MR scanning: preg-
nancy, weight inappropriate for height, ferrous objects within 
the body, or a history of claustrophobia; 5) left-handedness 
or ambidexterity (laterality quotient [LQ] < 50) as assessed 
with the Edinburgh Handedness Inventory [62]; or 6) use of 
medications that may affect the hemodynamic response in 
the scanner. 
 Seventy-eight community-dwelling older adults meeting 
study inclusion and exclusion requirements served as study 
participants (Table 1). Family history of dementia was pre-
sent in 51.3% of participants; 33.3% of the sample carried 
the APOE ?4 allele. One participant was a homozygous car-
rier of the ?4 allele; the remaining 25 carriers were heterozy-
gous (?3, ?4). Among the non-carriers, there were 44 persons 
who were homozygous ?3 carriers and 8 persons who were 
heterozygous (?2, ?3). At baseline, all participants completed 
the PA survey, but three participants did not complete the 
CA survey. Baseline neuropsychological evaluation revealed 
that all participants were initially cognitively intact accord-
ing to the measures described above. All participants were 
Caucasian. Written informed consent was obtained and all 
participants received financial compensation for time and 
travel.  
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Table 1. Means (and SDs) of Demographic and Neuropsychological Test Results for Stable and Declining Participants. SDs are Provided in 
Parentheses 
Variable Stable (n=51) Declining (n=27) 
Age (years) 72.6 (5) 73.6 (4.7) 
Education (years) 15.1 (2.4) 14.5 (3.2) 
Test-Retest Interval (days) 551.7 (43.5) 560.6 (47.0) 
Ethnicity 100% Caucasian 100% Caucasian 
Family History Status 27 Dementia -, 24 Dementia + 11 Dementia -, 16 Dementia + 
APOE allele status* 
39 ?4- (5 ?2?3, 34 ?3?3),  
12 ?4+ (11 ?3?4, 1 ?4?4) 
13 ?4- (3 ?2?3, 10 ?3?3),  
14 ?4+ (all ?3?4) 
Gender 13 Males, 38 Females 8 Males, 19 Females 
Cognitive Activity (Sum) 25.9 (2.8) 26.7 (2.8) 
Physical Activity 25 Low PA, 26 High PA 16 Low PA, 11 High PA 
Baseline Cognitive Results   
DRS-2 Total 140.7 (3.2) 139.7 (3.8) 
RAVLT Trials 1-5 50.6 (8.8) 46.8 (8.1) 
RAVLT DR 10.1 (2.6) 9.0 (2.8) 
Lawton IADL 5 (0) 5 (0) 
GDS* 2.7 (2.5) 1.4 (1.8) 
MMSE 29.4 (0.8) 28.9 (1.2) 
Follow-up Cognitive Results   
DRS-2 Total** 139.5 (2.1) 135.6 (5.0) 
RAVLT Trials 1-5** 49.5 (7.5) 40.1 (7.1) 
RAVLT DR** 10.2 (2.4) 6 (2.3) 
Lawton IADL 4.98 (0.14) 4.96 (0.19) 
GDS* 2.6 (2.6) 1.3 (1.8) 
MMSE 29.5 (1.1) 29.0 (1.2) 
Note: IADL=Instrumental Activities of Daily Living; GDS=Geriatric Depression Scale; MMSE=Mini-Mental State Examination; DRS-2=Mattis Dementia Rating Scale-2; 
RAVLT=Rey Auditory Verbal Learning Test;  *p<.05 between-groups. **p<.001. 
 
Neuropsychological Assessment and APOE Genotyping 
 Participants underwent baseline neuropsychological test-
ing, fMRI scanning, and APOE genotyping. The neuropsy-
chological battery included the MMSE, GDS, MDRS-2, 
RAVLT, and Lawton Instrumental Activities of Daily Living 
Scale. Each of these measures is commonly used in dementia 
assessment. The MMSE is a brief, 30-point measure of cog-
nitive status. The GDS is a 30-item measure of the presence 
or absence of depressive symptoms that has been well vali-
dated with older adults. The MDRS-2 provides an index of 
global cognitive functioning as well as domain-specific per-
formance measures in five cognitive domains (Attention, 
Initiation/Perseveration, Construction, Conceptualization, 
and Memory). The RAVLT consists of a list of 15 unrelated 
words that is presented to the participant over five study-test 
trials. In order to test susceptibility to proactive and retroac-
tive interferences, a distractor list of words is then presented 
in a study-test format, followed by a trial requiring the par-
ticipant to recall the original list of words. Finally, 30-minute 
delayed recall and recognition of the original list are as-
sessed. Although the RAVLT provides a number of memory 
performance indices, the current study examined the Sum of 
Words Recalled across Trials 1-5 (a measure of immediate 
learning capability) and 30-minute Delayed Recall (as a 
measure of delayed retention). Finally, the Lawton Instru-
mental Activities of Daily Living Scale evaluates the extent 
of functional independence by surveying capacity to carry 
out both instrumental and personal self-maintenance activi-
ties of daily living. APOE genotype was determined from 
whole blood using a PCR method [63]. An 18-month follow-
up neuropsychological evaluation was completed using al-
ternate forms of the DRS-2 [64, 65] and RAVLT [66]. 
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PA Survey 
 Participation in PA was assessed at baseline with the 
Stanford Brief Activities Survey "(SBAS; [67])” which has 
been validated for assessment of habitual PA in older adults 
[67, 68] and has shown significant, dose-dependent relation-
ships with cardiovascular risk factors and estimated energy 
expenditure in a large sample [67]. Survey items pertained to 
PA performed over the previous year. Participants who re-
ported two or fewer instances of low intensity PA (e.g., go-
ing for walks, doing chores, or playing golf) per week were 
assigned to the low PA group. Participants who reported 
moderate (e.g., brisk walking for 15 minutes; performing 
moderately difficult chores for 45 minutes) to heavy (e.g., 
jogging for 30 minutes; moderately difficult chores for 60 
minutes) PA at least three times a week were assigned to the 
high PA group. The group designation criteria for the high 
PA group are roughly consistent with the recommendations 
for minimum physical activity participation in healthy older 
adults that are expected to confer health benefits, while the 
low PA group did not meet this recommendation [20]. 
CA Survey 
 Participation in CA was assessed at baseline using the 
Cognitive Activities Scale “(CAS; [17])” a previously estab-
lished composite index of CA frequency [7, 11, 12, 17]. Par-
ticipants were asked about their frequency of participation in 
seven cognitively stimulating activities: viewing television, 
listening to radio, reading newspapers, reading magazines, 
reading books, playing games (e.g., cards, checkers, cross-
words, puzzles), and going to museums. Participants used a 
five-point Likert-type rating scale to indicate their current 
frequency of participation for each activity, where 5 = every 
day or about every day, 4 = several times a week, 3 = several 
times a month, 2 = several times a year, and 1 = once a year 
or less. Scores from all seven activities were summed to 
form a composite index of participation in CA, ranging from 
7 to 35. 
Definition of Cognitive Decline 
 Significant cognitive decline was defined as exhibiting a 
one SD reduction or greater on at least one of the three prin-
cipal outcome indices (DRS-2, RAVLT Sum of Trials 1-5, 
RAVLT Delayed Recall). Standardized residual change 
scores were computed [52] to adjust for baseline perform-
ance, practice effects, and regression to the mean [69-71]. 
Participants with standardized residual scores of -1.0 or 
lower for at least one neuropsychological measure consti-
tuted the cognitively declining group; the remaining partici-
pants were classified as cognitively stable. Because age may 
influence the likelihood of cognitive decline, age-corrected 
scores on each of these measures were also used to compute 
standardized residual change scores. The results using age-
corrected residual change scores did not differ from non-
corrected change scores, which may have been a function of 
the relatively brief test-retest interval of 18 months. There-
fore, our definition of cognitive decline in the analyses that 
follow used residual change scores that are not corrected for 
age. 
 
fMRI Task 
 For the famous name discrimination task [72], partici-
pants viewed individually presented names of well-known 
public figures (famous) or names drawn at random from a 
local telephone book (unfamiliar). Stimuli consisted of 30 
famous and 30 unfamiliar names that were randomly inter-
spersed with 20 presentations of a centrally placed crosshair 
to introduce “jitter” into the fMRI time course. Stimuli were 
presented using a fixed interstimulus interval of 4 sec. The 
imaging run started and ended with 12 secs of fixation. Total 
time for the single imaging run is 5 min and 24 sec. By using 
an event-related fMRI design, we are able to exclude the 
occasional incorrect item from the derived activation maps 
and avoid other methodological concerns associated with a 
blocked design format (e.g., strategy deployment). Partici-
pants made a right index or right middle finger key press for 
famous or unfamiliar names, respectively. Accuracy and 
reaction time were recorded.  
Image Acquisition 
 Whole-brain, event-related fMRI was conducted on a 
General Electric (Waukesha, WI) Signa Excite 3.0 Tesla 
short bore scanner equipped with a quad split quadrature 
transmit/receive head coil. Echoplanar images were collected 
using an echoplanar pulse sequence (TE=25 ms; flip an-
gle=77 degrees; field of view (FOV)=24 cm; matrix size=64 
x 64; TR=2 secs). Thirty-six contiguous axial 4-mm-thick 
slices provided whole brain coverage (voxel size = 3.75 x 
3.75 x 4 mm). High-resolution, three-dimensional spoiled 
gradient-recalled at steady-state (SPGR) anatomic images 
were acquired (TE = 3.9 ms; TR = 9.5 ms; inversion recov-
ery (IR) preparation time = 450 ms; flip angle = 12 degrees; 
number of excitations (NEX) = 2; slice thickness = 1.0 mm; 
FOV = 24 cm; resolution = 256 x 224). Foam padding was 
used to reduce head movement within the coil.  
Hippocampal Activation 
 Functional images were generated with the Analysis of 
Functional NeuroImages (AFNI) software package [73]. 
Each image series was time-shifted to the beginning of the 
TR and spatially registered to reduce head motion effects 
using a rigid body iterative linear least squares method. A 
deconvolution analysis was used to extract separate hemody-
namic response functions (HRFs) for correctly recognized 
famous and unfamiliar names. HRFs were modeled for the 0-
16 second period post-stimulus onset. Motion parameters 
and incorrect trials were incorporated into the model as nui-
sance regressors. Area under the curve (AUC) was calculated 
by summing the hemodynamic responses at time points 4, 6, 
and 8 seconds post-trial onset. Anatomical and functional 
scans were transformed into standard stereotaxic space [74], 
and functional images were blurred using a 6-mm Gaussian 
filter.  
 A voxelwise t-test contrasting semantic activation during 
correct discrimination of famous names versus unfamiliar 
names (AUCs) was performed on all participants. The statis-
tical threshold was based on an individual voxel probability 
(p = 0.005) coupled with a minimum cluster volume (0.73 
ml). These values were derived from 3,000 Monte Carlo 
simulations [75] and correspond to a whole brain family-
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wise error threshold of p < 0.05. This approach identified 
significant clusters representing functional regions of interest 
(fROIs; [52]). Across all voxels within each fROI, an “aver-
age AUC” was computed for each participant. Using these 
data, a principal components analysis (PCA) further reduced 
the number of regions that would serve as predictors in the 
logistic regression analysis. Two components were identi-
fied, representing cortical (bilateral posterior cingulate/ pre-
cuneus, left angular gyrus, left superior frontal gyrus, right 
angular gyrus, right superior middle frontal gyrus) and hip-
pocampal (right and left parahippocampal gyrus/ hippocam-
pus) regions of increased semantic activation during correct 
identification of famous names relative to unfamiliar names. 
Because this study focused on hippocampal volume and 
function, only the latter component was used in logistic re-
gression models. 
Hippocampal Volume 
 Left and right hippocampal volumes were obtained using 
Freesurfer [76, 77] and manually edited on T1-weighted 
SPGR images by two raters blinded to participant group 
membership as described previously [52]. Hippocampal vol-
umes were normalized by dividing by the total intracranial 
volume. Intraclass correlation for the two raters was 0.87. 
The left and right hippocampal volumes were then summed 
to create a single value. 
Data Analysis 
 We tested two initial logistic regression models that pre-
dicted cognitive decline at 18-month follow-up using APOE 
?4 allele status, either baseline PA or CA, and the APOE ?4 
allele status by activity interaction. Next, we tested several 
logistic regression models to determine whether addition of 
the baseline neuroimaging variables as covariates would 
enhance prediction of cognitive decline beyond APOE ?4 
allele status and participation in CA or PA alone.  
RESULTS 
Demographics and Baseline and Follow-up Neuropsy-
chological Scores 
 Twenty-seven of the 78 participants demonstrated a one 
SD decline on one or more of the three principal neuropsy-
chological measures (DRS-2, RAVLT Sum of Trials 1-5, 
RAVLT Delayed Recall). Participant demographics, neuro-
psychological performance, PA and CA data for the  
stable (n=51) and declining (n=27) groups are presented in 
Table 1. Importantly, there were no significant differences 
between the stable and declining groups on age, education, 
or gender representation. There was a non-significant trend 
for the declining group to have slightly lower baseline scores 
on the MMSE, RAVLT Sum of Trials 1-5, and RAVLT De-
layed Recall relative to the stable group. The stable group 
demonstrated significantly greater baseline mean scores on 
the GDS, although neither the stable nor declining groups 
scored in the clinical range on this measure. Although there 
was a significantly higher proportion of APOE ?4 carriers in 
the declining group, there were no significant differences 
between groups with respect to other demographic variables 
or extent of engagement in PA or CA. At follow-up, the neu-
ropsychological scores in Table 1 reveal that the declining 
group clearly demonstrated significant reductions on all three 
of the measures used to define the groups (DRS-2, RAVLT 
Sum of Trials 1-5, and RAVLT Delayed Recall). There was 
no significant change in the level of depressive symptoms 
reported on the GDS over the two assessments. 
Influence of CA and PA on Cognitive Decline 
 Table 2 shows the results of several logistic regression 
models investigating how well CA, APOE ?4 allele status, 
hippocampal volume, and fMRI-measured semantic process-
ing activity help predict probability of cognitive decline after 
18 months. Each model’s ability to discriminate between 
stable and declining participants was evaluated with 
Nagelkerke R
2 
and the concordance or C index (related to the 
area under the receiver operating characteristic curve; [78]). 
The Nagelkerke R
2 
reflects the collective importance of the 
predictors in each model as compared to a “perfectly fitting” 
null model [79]. The C index reflects the proportion of all 
possible pairs of declining and stable subjects in which the 
declining participant in the pair had a higher predicted prob-
ability of decline than the stable participant [78].  
Baseline Models 
 Two baseline models were established in order to assess 
the combined influence of factors other than CA and PA that 
might also be predictive of cognitive decline at 18-month 
follow-up. These models included APOE ?4 allele status and 
either baseline hippocampal fMRI semantic processing activ-
ity (Model 1A) or baseline hippocampal volume (Model 1B). 
Although both models exhibited comparable C indices (.72), 
the model that included APOE ?4 allele status and hippo-
campal fMRI activity yielded a slightly stronger R
2
 (.203). 
Models assessing the impact of CA and PA on cognitive 
decline at follow-up were contrasted against these baseline 
models. 
Effect of CA on Cognitive Decline 
 A logistic regression model that included only APOE ?4 
allele status, participation in CA and the interaction between 
these two variables (Model 2A) was not statistically signifi-
cant. For Model 2B, which added baseline hippocampal 
fMRI semantic processing activity as a covariate, only the 
hippocampal fMRI index emerged as a significant predictor. 
For Model 2C, there were no significant effects, although 
baseline hippocampal volume demonstrated a non-significant 
trend (p=.07) toward significance. For Models 2B and 2C, 
addition of the neuroimaging variables enhanced the C index 
and R
2
 values relative to Model 2A. Because these increases 
were principally driven by the neuroimaging variables, it 
does not appear that participation in CA affects the predicted 
probability of cognitive decline. In addition, relative to the 
two baseline models (Models 1A and 1B), the models that 
added CA and its interaction with APOE ?4 allele status did 
not result in appreciably different C indices or R
2
 values. 
Effect of PA on Cognitive Decline 
 The logistic regression model that included PA (high vs. 
low), APOE ?4 allele status, and their interaction (Model 
3A) was statistically significant. APOE ?4 allele status and
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Table 2. Logistic Regression Results Testing Effects of Neuroimaging Results, APOE ?4 Allele Status, and Physical or Cognitive 
Activity on Cognitive Decline 
Baseline Model 1A C=.719 R2=.203   Baseline Model 1B C=.716 R2=.178  
Effect Coefficient SE Wald Z p Effect Coefficient SE Wald Z p 
Intercept -1.23 0.35 -3.54 4E-4 Intercept 3.30 2.16 1.52 .127 
Hippocampal fMRI -0.70 0.31 -2.23 .025 Hippocampal volume -0.99 0.49 -2.02 .043 
APOE ?4 genotype 1.40 0.54 2.60 .009 APOE ?4 genotype 1.06 0.53 -2.00 .045 
Cognitive Activity Models Physical Activity Models 
Model 2A C=.640 R2=.104  Model 3A C=.680 R2=.208  
Effect Coefficient SE Wald Z p Effect Coefficient SE Wald Z p 
Intercept -1.01 0.41 -2.45 .014 Intercept -1.19 0.432 -2.76 .006 
APOE ?4 genotype 0.61 0.77 0.79 .429 APOE ?4 genotype 2.69 0.893 3.02 .003 
CA level -0.09 0.66 -0.13 .895 PA status 0.21 0.645 0.32 .746 
APOE ?4 genotype * CA 
level 
0.90 1.06 0.84 .399 
APOE ?4 genotype * PA 
level 
-2.41 1.152 -2.09 .037 
Model 2B C=.724 R2=.209  Model 3B C=.741 R2=.304  
Effect Coefficient SE Wald Z p Effect Coefficient SE Wald Z p 
Intercept -1.09 0.43 -2.51 .012 Intercept -1.42 0.47 -3.01 .003 
Hippocampal fMRI  -0.72 0.32 -2.28 .023 Hippocampal fMRI  -0.81 0.35 -2.29 .022 
APOE ?4 genotype 0.63 0.79 0.79 .428 APOE ?4 genotype 3.04 0.96 3.17 .002 
CA level -0.20 0.69 -0.29 .773 PA level 0.36 0.68 0.53 .597 
APOE ?4 genotype * CA 
level 
1.17 1.12 1.04 .296 
APOE ?4 genotype * PA 
level 
-2.75 1.22 -2.24 .025 
Model 2C C=.703 R2=.163  Model 3C C=.742 R2=.258  
Effect Coefficient SE Wald Z p Effect Coefficient SE Wald Z p 
Intercept 2.92 2.18 1.34 .181 Intercept 3.02 2.37 1.27 .202 
Hippocampal volume -0.90 0.50 -1.81 .070 Hippocampal volume -0.93 0.52 -1.78 .075 
APOE ?4 genotype 0.56 0.78 0.72 .474 APOE ?4 genotype 2.36 0.92 2.56 .011 
CA status 0.09 0.68 0.13 .897 PA level -0.01 0.67 -0.02 .985 
APOE ?4 genotype * CA 
level 
0.67 1.09 0.62 .538 
APOE ?4 genotype * PA 
level 
-2.08 1.18 -1.76 .079 
 
 the interaction between PA and APOE ?4 status were sig-
nificant predictors. Inspection of the simple effects of this 
interaction revealed that the predicted probability of decline 
for the APOE ?4 positive participants who reported low PA 
was significantly higher compared to APOE ?4 carriers who 
reported high PA. However, the predicted probability of de-
cline was not affected by PA level for APOE ?4 negative 
participants Fig. (1).  
 For models 3B and 3C, we added indices of baseline hip-
pocampal function and structure as covariates to determine 
their relationship with prediction of cognitive decline at  
18-month follow-up when combined with APOE ?4 allele 
status and PA level. Relative to Model 3A, addition of the 
neuroimaging covariates increased the Nagelkerke R
2
 and C 
index values by 5-10%, depending on the model. For Model 
3B, APOE ?4 allele status and baseline hippocampal fMRI 
semantic activation were significant predictors of decline. 
For Model 3C, although APOE ?4 allele status was a signifi-
cant predictor, total hippocampal volume at baseline demon-
strated a non-significant trend (p=.075) as a covariate. For 
both Models 3B and 3C, the main effect of PA status was not 
significant. However, the interaction between PA and APOE 
?4 status was significant in Model 3B (p=.032) but demon-
strated a non-significant trend in Model 3C, where baseline 
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total hippocampal volume was included as a covariate 
(p=.079). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Differences between predicted probabilities of decline for 
high and low PA groups as a function of APOE ?4 allele status. 
Error bars reflect the 95% confidence intervals. Low PA ?4 carriers 
(n=11) demonstrated a higher probability of decline than low PA ?4 
non-carriers (n=30), high PA ?4 carriers (n=15), and high PA ?4 
non-carriers (n=22). 
 
 To better elucidate the interaction between PA and APOE 
?4 allele status in Model 3B, we held the covariate (baseline 
hippocampal fMRI semantic processing activity) constant at 
the mean and at several 0.5 SD increments above and below 
the mean. Then, for APOE ?4 positive and negative indi-
viduals separately, we plotted the differences between the 
predicted probabilities of decline for high and low PA par-
ticipants. The upper two graphs in Fig. (2) display the differ-
ence in predicted probabilities of decline for the low PA 
group minus the high PA group at each incremental level of 
baseline hippocampal activity.  
 For APOE ?4 negative participants (Fig. (2), upper left 
panel), there was no significant difference between the pre-
dicted probabilities of decline for high and low PA partici-
pants. However, for APOE ?4 positive participants (Fig. (2), 
upper right panel), the predicted probability of decline asso-
ciated with low PA is significantly higher than that for high 
PA. Further inspection suggests that the relative advantage 
conferred by PA in reducing the probability of cognitive 
decline decreases as hippocampal fMRI semantic processing 
activity decreases from values that are 0.5 SD above the 
mean. Smaller PA-related differences in predicted probabil-
ity of decline were also seen as fMRI semantic processing 
activity increased above 0.5 SD beyond the mean. Impor-
tantly, there were no significant differences in predicted 
probability of decline for high and low PA participants when 
hippocampal semantic processing activity was 2 SD above or 
below the mean. 
 Although the overall interaction was not significant, Fig. 
(2) (lower two panels) demonstrates similar trends for base-
line hippocampal volume. The protective effect of PA over 
physical inactivity is not significantly different when base-
line hippocampal volume is held constant at 2 SD above or 
below the mean. 
DISCUSSION 
 Our major finding is that high PA was associated with a 
reduced likelihood of cognitive decline in APOE ?4 carriers. 
In contrast, PA level did not influence the probability of de-
cline in APOE ?4-negative participants. Moreover, greater 
engagement in PA tended to confer progressively smaller 
advantages over low PA as hippocampal fMRI semantic 
processing activity decreased. That is, as hippocampal func-
tion declines, the effectiveness of PA as an intervention 
against cognitive decline may become attenuated. A similar 
trend was seen with smaller baseline hippocampal volumes. 
These findings suggest the importance of beginning a PA 
regimen as early as possible, prior to the occurrence of sub-
stantial hippocampal volume or functional activity loss that 
might be attributable to disease-related factors. In addition, 
higher levels of hippocampal fMRI semantic processing ac-
tivity were also associated with smaller differences in pre-
dicted probability of decline between the high and low PA 
groups. This finding could be attributable to the effects of 
cognitive reserve, suggesting that greater levels of hippo-
campal integrity may buffer against cognitive decline [6]. In 
addition, PA may play a neuroprotective role by reducing 
age-related declines in gray and white matter density [80] 
and hippocampal atrophy [35]. Individuals with intact and 
highly functional hippocampi may be at lower risk of cogni-
tive decline regardless of their PA level [81-86]. 
 High and low PA APOE ?4 non-carriers did not show 
any difference in predicted probability of decline, regardless 
of fMRI semantic processing activity or baseline hippocam-
pal volume. While generally beneficial associations between 
PA and cognitive functioning have been reported in humans, 
other studies have reported null findings [5, 11-13, 87]. Our 
findings are consistent with results from a study showing 
that a lack of PA posed a greater risk of cognitive decline in 
older male APOE ?4 carriers than non-carriers [23]. In addi-
tion, our results support findings that midlife physical activ-
ity was associated with greater reductions in the risk of inci-
dent dementia and AD in APOE ?4 carriers relative to non-
carriers after an average follow-up of 21 years [31]. In con-
trast, in a large, population-based study, lack of PA was as-
sociated with an increased number of incident dementia 
cases only in APOE ?4 non-carriers [32]. Important differ-
ences between this study and ours that could account for the 
apparent discrepant effects of PA in APOE ?4 non-carriers 
include outcome measure (e.g., cognitive decline vs. incident 
dementia), timing and duration of PA, and the approach used 
to assess PA. These methodological differences will be im-
portant to examine in future research. 
 Finally, participation in CA was not predictive of subse-
quent cognitive decline in our logistic regression models. 
This finding contrasts with results from a prior study utiliz-
ing the CAS [7]. However, in that study, the sample size was 
very large (n = 4392), follow-up occurred over a longer time 
frame than in the current study (average follow-up: 5.3 years 
vs. 18 months), and cognitive decline was coded as a con-
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tinuous rather than a dichotomous variable, utilizing a com-
posite z-score from four tests of cognitive function [7].  
 Our results complement the findings of a recent study 
[35] demonstrating that a one-year PA intervention can in-
crease hippocampal volume in older adults. Specific PA-
associated improvement in spatial memory was associated 
with increased volume of the anterior hippocampus. Our 
study extends these results by directly examining the longi-
tudinal effects of both CA and PA on risk for cognitive de-
cline using both sMRI , fMRI and by focusing on APOE ?4 
allele as a moderator of the relationship between cognitive 
decline and hippocampal structure and function. Future in-
terventional research should examine whether different in-
tensities of PA exert varying effects on hippocampal volume 
and function and whether they have differential impacts on 
the trajectory of cognitive decline. Additionally, future stud-
ies might investigate whether the benefits of PA interven-
tions are reduced in asymptomatic elders with below average 
hippocampal volume and/or functional integrity, as sug-
gested by our results. 
 Although this study represents the first to incorporate 
both functional and anatomical brain imaging to assess the 
effects of lifestyle and genetic risk on cognitive functioning, 
limitations of our study should be considered. Our sample 
size and relatively brief follow-up period may have limited 
our ability to detect a relationship between cognitively 
stimulating activities and cognitive decline. A more ex-
panded survey of CA, including activities such as playing 
musical instruments, going to classes, studying, painting, 
cooking food, and going to theatres or concerts, may provide 
greater sensitivity to predicting cognitive decline [10, 13-15, 
88-91]. Additionally, in our study, we dichotomized partici-
pants into high and low PA groups; other PA questionnaires 
estimate energy expenditure during PA as a continuous vari-
able [92-95]. An even better approach would involve the use 
of accelerometry to objectively measure PA or the prospec-
tive engagement in a controlled physical exercise training 
program.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). (upper two graphs).  Simple effects of the APOE ?4 * PA interaction, holding hippocampal fMRI semantic processing activity con-
stant at selected values 2 SD above and below the mean.  Closed circles represent the predicted probability of decline for the low PA group 
minus the predicted probability of decline for the high PA group, and error bars reflect the 95% confidence intervals.  Note that there is no 
significant difference between predicted probabilities of decline for low and high PA participants for hippocampal fMRI activity values at +2 
and -2 SD from the mean.  The difference between predicted probabilities of decline for high and low PA participants appears to be greatest 
at 0.5 SD above the mean and becomes smaller as hippocampal activity values decrease (possibly reflecting the loss of hippocampal func-
tion) or increase (possibly reflecting the effects of cognitive reserve). Fig. (2) (lower two graphs).  Simple effects of the APOE ?4 * PA inter-
action, holding hippocampal volume constant at selected values 2 SD above and below the mean.  Closed circles represent the predicted 
probability of decline for the low PA group minus the predicted probability of decline for the high PA group, and error bars reflect the 95% 
confidence intervals.  Note that there is no significant difference between predicted probabilities of decline for high and low PA participants 
for hippocampal volumes that are +2 SD from the mean, and the difference approaches 0 for hippocampal volumes that are -2 SD from the 
mean.  As in the upper two graphs, the difference between predicted probabilities of decline for low and high PA participants appears to be 
greatest at 0.5 SD above the mean and becomes smaller as hippocampal volumes decrease (possibly reflecting the loss of hippocampal func-
tion) or increase (possibly reflecting the effects of cognitive reserve). 
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CONCLUSION 
 Results of our study revealed that engagement in leisure-
time PA, but not CA, is associated with a reduced probability 
of cognitive decline over 18 months in healthy older APOE 
?4 carriers. Furthermore, addition of baseline fMRI semantic 
processing activity or baseline hippocampal volume as co-
variates enhanced prediction of future decline. We did not 
find an effect of participation in PA or CA on risk of cogni-
tive decline in APOE ?4 non-carriers. When the simple ef-
fects of the APOE ?4 allele status by PA interaction were 
examined, the difference between the predicted probabilities 
of decline for high and low PA APOE ?4 carriers decreased 
with lower levels of hippocampal fMRI semantic processing 
activity and hippocampal volume. This trend may suggest 
decreasing benefits of PA in persons with lower levels of 
hippocampal function or reduced hippocampal volume. 
Smaller differences in predicted probability of decline for the 
two PA groups were also observed with greater hippocampal 
volume or higher levels of hippocampal fMRI activity. This 
finding suggests that greater hippocampal volume and func-
tion reflect greater cognitive reserve and buffer against cog-
nitive decline [6]. 
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